Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Influence of calcium concentration in haemodialysis fluid on blood pressure control.

Ampuero Mencía J, Vega A, Abad S, Ruiz Caro C, Verdalles Ú, López Gómez JM.

Nefrologia. 2019 Jan - Feb;39(1):44-49. doi: 10.1016/j.nefro.2018.04.008. Epub 2018 Jul 31. English, Spanish.

2.

Follow a recipe to prescribe phosphate during hemodialysis.

Albalate M, Ruiz-Alvarez MJ, de Sequera P, Perez-Garcia R, Arribas P, Corchete E, Ruiz Caro C, Talaván Zanón T, Alcazar R, Ortega M, Puerta M.

Nefrologia. 2017 Jan - Feb;37(1):34-38. doi: 10.1016/j.nefro.2016.04.005. Epub 2016 Jul 25. English, Spanish.

3.

Factors related with the progression of chronic kidney disease.

Yuste C, Barraca D, Aragoncillo-Sauco I, Vega-Martínez A, Abad S, Verdalles-Guzmán Ú, Ruiz-Caro C, Ampuero J, López-Gómez JM.

Nefrologia. 2013;33(5):685-91. doi: 10.3265/Nefrologia.pre2013.May.11900.

4.

Chronic kidney disease progression in patients with autosomal dominant polycystic kidney disease.

Panizo N, Goicoechea M, García de Vinuesa S, Arroyo D, Yuste C, Rincón A, Verdalles U, Ruiz-Caro C, Quiroga B, Luño J.

Nefrologia. 2012;32(2):197-205. doi: 10.3265/Nefrologia.pre2011.Dec.11177. Epub 2012 Jan 27. English, Spanish.

5.

Factors related to the absence of anemia in hemodialysis patients.

Verdalles U, Abad S, Vega A, Ruiz Caro C, Ampuero J, Jofre R, Lopez-Gomez JM.

Blood Purif. 2011;32(1):69-74. doi: 10.1159/000323095. Epub 2011 Feb 24.

PMID:
21346339
6.

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.

Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincón A, Arroyo D, Luño J.

Clin J Am Soc Nephrol. 2010 Aug;5(8):1388-93. doi: 10.2215/CJN.01580210. Epub 2010 Jun 10.

Supplemental Content

Loading ...
Support Center